1. Anticancer effects of isofraxidin against A549 human lung cancer cells via the EGFR signaling pathway
    Han Zhang et al, 2018, Molecular Medicine Reports CrossRef

  2. In vitro and in vivo Study of a Novel Liposome-Mediated Dual Drug Delivery for Synergistic Lung Cancer Therapy via Oral Administration


    Qi Zhou et al, 2020, OncoTargets and Therapy CrossRef
  3. Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation
    Yi-Pei Lin et al, 2019, Oncogene CrossRef

  4. Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells


    Yuzhou Shen et al, 2020, Drug Design, Development and Therapy CrossRef